Svai Sanford
2023
In 2023, Svai Sanford earned a total compensation of $2.2M as Chief Financial Officer at Rani Therapeutics Holdings, a 9% increase compared to previous year.
Compensation breakdown
| Option Awards | $983,836 |
|---|---|
| Salary | $416,000 |
| Stock Awards | $756,160 |
| Total | $2,155,996 |
Sanford received $983.8K in option awards, accounting for 46% of the total pay in 2023.
Sanford also received $416K in salary and $756.2K in stock awards.
Rankings
In 2023, Svai Sanford's compensation ranked 482nd out of 3,006 executives tracked by ExecPay. In other words, Sanford earned more than 84.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 482 out of 3,006 | 84th |
Division Manufacturing | 277 out of 1,650 | 83rd |
Major group Chemicals And Allied Products | 191 out of 918 | 79th |
Industry group Drugs | 188 out of 881 | 79th |
Industry Pharmaceutical Preparations | 119 out of 637 | 81st |
Source: SEC filing on April 17, 2024.
Sanford's colleagues
We found two more compensation records of executives who worked with Svai Sanford at Rani Therapeutics Holdings in 2023.